313 related articles for article (PubMed ID: 16498364)
1. Aromatase enzyme and Alzheimer's disease.
Hiltunen M; Iivonen S; Soininen H
Minerva Endocrinol; 2006 Mar; 31(1):61-73. PubMed ID: 16498364
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation of CYP19 (aromatase) gene influences age at onset of Alzheimer's disease in women.
Corbo RM; Gambina G; Ulizzi L; Moretto G; Scacchi R
Dement Geriatr Cogn Disord; 2009; 27(6):513-8. PubMed ID: 19478482
[TBL] [Abstract][Full Text] [Related]
3. Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease.
Ishunina TA; van Beurden D; van der Meulen G; Unmehopa UA; Hol EM; Huitinga I; Swaab DF
Neurobiol Aging; 2005 Feb; 26(2):173-94. PubMed ID: 15582747
[TBL] [Abstract][Full Text] [Related]
4. Interference of endocrine disrupting chemicals with aromatase CYP19 expression or activity, and consequences for reproduction of teleost fish.
Cheshenko K; Pakdel F; Segner H; Kah O; Eggen RI
Gen Comp Endocrinol; 2008 Jan; 155(1):31-62. PubMed ID: 17459383
[TBL] [Abstract][Full Text] [Related]
5. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
6. Aromatase and prostate cancer.
Ellem SJ; Risbridger GP
Minerva Endocrinol; 2006 Mar; 31(1):1-12. PubMed ID: 16498360
[TBL] [Abstract][Full Text] [Related]
7. Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk.
Combarros O; Riancho JA; Infante J; Sañudo C; Llorca J; Zarrabeitia MT; Berciano J
Dement Geriatr Cogn Disord; 2005; 20(2-3):153-7. PubMed ID: 16020944
[TBL] [Abstract][Full Text] [Related]
8. Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease?
Morale MC; L'Episcopo F; Tirolo C; Giaquinta G; Caniglia S; Testa N; Arcieri P; Serra PA; Lupo G; Alberghina M; Harada N; Honda S; Panzica GC; Marchetti B
Brain Res Rev; 2008 Mar; 57(2):431-43. PubMed ID: 18063054
[TBL] [Abstract][Full Text] [Related]
9. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease.
Xu H; Wang R; Zhang YW; Zhang X
Ann N Y Acad Sci; 2006 Nov; 1089():324-42. PubMed ID: 17261779
[TBL] [Abstract][Full Text] [Related]
10. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization.
Spratt DI; Morton JR; Kramer RS; Mayo SW; Longcope C; Vary CP
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E631-8. PubMed ID: 16670151
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism in genes involved in adrenergic signaling associated with Alzheimer's.
Bullido MJ; Ramos MC; Ruiz-Gómez A; Tutor AS; Sastre I; Frank A; Coria F; Gil P; Mayor F; Valdivieso F
Neurobiol Aging; 2004 Aug; 25(7):853-9. PubMed ID: 15212839
[TBL] [Abstract][Full Text] [Related]
12. Aromatase, the enzyme responsible for estrogen biosynthesis, is expressed by human and rat glioblastomas.
Yague JG; Lavaque E; Carretero J; Azcoitia I; Garcia-Segura LM
Neurosci Lett; 2004 Sep; 368(3):279-84. PubMed ID: 15364411
[TBL] [Abstract][Full Text] [Related]
13. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
14. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.
Zhou XW; Gustafsson JA; Tanila H; Bjorkdahl C; Liu R; Winblad B; Pei JJ
Neurobiol Dis; 2008 Sep; 31(3):386-94. PubMed ID: 18586097
[TBL] [Abstract][Full Text] [Related]
15. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain.
Stockley JH; O'Neill C
Biochem Soc Trans; 2007 Jun; 35(Pt 3):574-6. PubMed ID: 17511655
[TBL] [Abstract][Full Text] [Related]
16. [Testicular aromatase].
Carreau S; Bourguiba S; Lambard S; Galeraud-Denis I
J Soc Biol; 2002; 196(3):241-4. PubMed ID: 12462076
[TBL] [Abstract][Full Text] [Related]
17. Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer's disease key proteins.
Schaeffer V; Patte-Mensah C; Eckert A; Mensah-Nyagan AG
J Neurobiol; 2006 Jul; 66(8):868-81. PubMed ID: 16673391
[TBL] [Abstract][Full Text] [Related]
18. Metallothionein-I and -III expression in animal models of Alzheimer disease.
Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J
Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170
[TBL] [Abstract][Full Text] [Related]
19. Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease.
Candore G; Balistreri CR; Grimaldi MP; Vasto S; Listì F; Chiappelli M; Licastro F; Lio D; Caruso C
Ann N Y Acad Sci; 2006 Nov; 1089():472-86. PubMed ID: 17261790
[TBL] [Abstract][Full Text] [Related]
20. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress.
Lee KW; Kim JB; Seo JS; Kim TK; Im JY; Baek IS; Kim KS; Lee JK; Han PL
J Neurochem; 2009 Jan; 108(1):165-75. PubMed ID: 19012747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
